Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Announces Quarterly Dividend of $0.30

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend on Monday, August 3rd. Investors of record on Friday, August 14th will be given a dividend of 0.30 per share by the real estate investment trust on Monday, August 31st. This represents a c) annualized dividend and a yield of 5.8%. The ex-dividend date is Friday, August 14th.

Sabra Healthcare REIT has decreased its dividend payment by an average of 0.0%per year over the last three years. Sabra Healthcare REIT has a dividend payout ratio of 153.8% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect Sabra Healthcare REIT to earn $1.59 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 75.5%.

Sabra Healthcare REIT Trading Down 2.6%

SBRA opened at $20.61 on Tuesday. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $22.77. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The stock has a market capitalization of $5.20 billion, a PE ratio of 32.71, a P/E/G ratio of 1.64 and a beta of 0.64. The firm’s fifty day moving average price is $19.77 and its 200 day moving average price is $19.93.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on SBRA shares. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. UBS Group set a $25.00 price objective on Sabra Healthcare REIT in a report on Wednesday, July 22nd. Wells Fargo & Company upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Finally, Barclays began coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 target price on the stock. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $22.25.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.